首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1900206篇
  免费   141003篇
  国内免费   5308篇
耳鼻咽喉   24593篇
儿科学   62400篇
妇产科学   50657篇
基础医学   284518篇
口腔科学   53009篇
临床医学   180356篇
内科学   364109篇
皮肤病学   39696篇
神经病学   151092篇
特种医学   69289篇
外国民族医学   430篇
外科学   270108篇
综合类   41504篇
现状与发展   3篇
一般理论   603篇
预防医学   155509篇
眼科学   42605篇
药学   142064篇
  9篇
中国医学   5129篇
肿瘤学   108834篇
  2021年   15085篇
  2019年   15780篇
  2018年   22237篇
  2017年   16897篇
  2016年   18429篇
  2015年   21015篇
  2014年   28802篇
  2013年   44222篇
  2012年   60228篇
  2011年   63752篇
  2010年   37198篇
  2009年   34470篇
  2008年   58615篇
  2007年   62149篇
  2006年   62747篇
  2005年   60020篇
  2004年   57598篇
  2003年   54761篇
  2002年   53214篇
  2001年   89236篇
  2000年   91493篇
  1999年   76379篇
  1998年   21057篇
  1997年   18642篇
  1996年   18730篇
  1995年   17787篇
  1994年   16534篇
  1993年   15413篇
  1992年   60104篇
  1991年   58960篇
  1990年   57211篇
  1989年   55117篇
  1988年   50739篇
  1987年   49353篇
  1986年   47015篇
  1985年   44630篇
  1984年   33301篇
  1983年   28375篇
  1982年   16572篇
  1979年   30320篇
  1978年   21434篇
  1977年   17776篇
  1976年   17284篇
  1975年   18131篇
  1974年   21935篇
  1973年   21290篇
  1972年   19789篇
  1971年   18417篇
  1970年   17304篇
  1969年   15838篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
There is a large and growing population of long-term cancer survivors. Primary care physicians (PCPs) are playing an increasingly greater role in the care of these patients across the continuum of cancer survivorship. In this role, PCPs are faced with the responsibility of managing a range of medical and psychosocial late effects of cancer treatment. In particular, the sexual side effects of treatment which are common and have significant impact on quality of life for the cancer survivor, often go unaddressed. This is an area of clinical care and research that has received increasing attention, highlighted by the presentation of this special issue on Cancer and Sexual Health. The aims of this review are 3-fold. First, we seek to overview common presentations of sexual dysfunction related to major cancer diagnoses in order to give the PCP a sense of the medical issues that the survivor may present with. Barriers to communication about sexual health issues between patient/PCPs in order are also described in order to emphasize the importance of PCPs initiating this important conversation. Next, we provide strategies and resources to help guide the PCP in the management of sexual dysfunction in cancer survivors. Finally, we discuss case examples of survivorship sexual health issues and highlight the role that a PCP can play in each of these case examples.  相似文献   
133.
134.
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets.  相似文献   
135.
136.
137.

Background

Arterial vascular anomalies in patients undergoing kidney transplantation (KT) are correlated with a higher incidence of early surgical complications, potentially causing graft loss. Arterial reconstruction allows patients to overcome these surgical challenges, thus minimizing the risk of poor outcomes. The aim of the present study is to retrospectively investigate the safety and effectiveness of the multiple arterial reconstruction technique with a Teflon patch in case of an unavailable aortic patch: to do so, surgical complications, graft function, and patient survival were evaluated.

Methods

During the period January 2009 to August 2016, 202 adult deceased-donor KTs were performed at our center. Group A (n = 27; reconstruction of multiple arteries) and Group B (n = 175; control group) were compared.

Results

No differences were observed between the 2 groups in terms of early postoperative course, with no vascular complication observed in Group A. No vascular patch infections were reported, nor longer cold ischemia time rates. Similarly, long-term survival rates were similar between the 2 groups.

Conclusions

The Teflon-patch arterial reconstruction technique appears to be safe and effective, with an acceptable balance of benefits and potential risks of using a prosthetic material. Studies based on larger series are needed to further validate this approach.  相似文献   
138.
139.
140.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号